We’re building foundation models for the human cell, harnessing AI to usher in a new era of human repair.
Location: United States
Total raised: $57.1M
Investors 2
| Date | Name | Website |
| - | TechAviv F... | techaviv.c... |
| 13.07.2025 | Chan Zucke... | chanzucker... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 18.05.2025 | Series A | $47M | - |
| 09.09.2024 | Pre-Seed | $4.8M | - |
| 16.04.2024 | Pre-Seed | $5.3M | - |
Mentions in press and media 14
| Date | Title | Description |
| 22.08.2025 | Somite.ai: Strategic Investment Raised From AMD Ventures | Somite.ai, a pioneering company dedicated to advancing foundation models for human stem cells, has recently announced a significant strategic investment from AMD Ventures. This announcement follows Somite’s successful $47 million Series A f... |
| 18.05.2025 | Somite AI: $47 Million Series A Raised To Accelerate Human Cell Therapy Development | Somite AI, a tech-bio company utilizing foundation models and proprietary AI to advance human cell therapy development, announced it closed a Series A funding round raising more than $47 million. The funding round was led by Khosla Ventures... |
| 13.05.2025 | Somite AI Raises $47M Series A To Reinvent Cell Replacement Therapy | Startup Somite AI announced today that it has raised over $47 million in a Series A funding round, bringing its total funding to about $60 million. The round was led by Khosla Ventures, with participation from SciFi VC, the Chan Zuckerberg ... |
| 13.05.2025 | Somite AI Raises Series A Funding | Somite AI, a Boston, MA-based TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, raised an undisclosed amount in Series A funding. The round was led by Khosla Ventures, with partici... |
| 09.09.2024 | Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite's Cell Therapy Flagship Program | CDMO collaboration propels cell replacement therapy targeting Duchenne muscular dystrophy forward, with consequences for the role of AI in cell therapy BOSTON and HAMILTON, Ontario, Sept. 9, 2024 /PRNewswire/ -- Somite Therapeutics, a tech-... |
| 09.09.2024 | Somite Therapeutics Raises $4.8M Extension of Pre-Seed Funding | Somite Therapeutics, a Boston, MA-based TechBio company leveraging big data and AI to introduce novel cell replacement therapies, raised a $4.8M extension of its pre-seed funding. This round, which brought total funds raised to over $10M, w... |
| 03.09.2024 | Somite Therapeutics Announces Round Extension with Astellas Venture Management and Montage Ventures Joining as Board Observers | To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the statement. BOSTON, Sept. 3, 2024 /PRNewswire/ -- Somite Therapeutics, a fully integrated TechBio company leverag... |
| 21.05.2024 | Prof. Jay Shendure Joins Somite Therapeutics as Scientific Co-founder | [[To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the statement.]] BOSTON, May 21, 2024 /PRNewswire/ -- Somite Therapeutics, a tech-bio company harnessing big data ... |
| 01.05.2024 | Somite Therapeutics to Present at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT) | [[To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the statement.]] BOSTON, May 1, 2024 /PRNewswire/ -- Somite Therapeutics, a tech-bio company leveraging big data a... |
| 16.04.2024 | Somite Raises $5.3M in Pre-Seed Funding | Somite, a Boston, MA-based developer of AI for stem cell biology, raised $5.3M in Pre-Seed funding. The round was led by TechAviv, and joined by Next Coast Ventures, Trust Ventures and Texas Venture Partners as well as Lerer Hippeau and oth... |
Show more